Taisho Pharmaceutical Pabron Gold A recall in Canada: Unlicensed product
In plain language
This recall involves Taisho Pharmaceutical Pabron Gold A (Granules) sold in Canada. It's being recalled because it is an unlicensed product and contains dihydrocodeine phosphate, a controlled substance. Stop using the product and consult your healthcare provider for any health concerns.
What to do
- Stop using the product immediately.
- Consult your healthcare provider for any health concerns.
- Contact the recalling firm if you have questions.
- Report any health product related side effects to Health Canada.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Specific affected products are listed in the official notice.
Do I have this product?
This recall applies to specific products. Details are listed in the official notice.
Frequently Asked Questions
Why was this product recalled?
This recall involves Taisho Pharmaceutical Pabron Gold A (Granules) sold in Canada. It's being recalled because it is an unlicensed product and contains dihydrocodeine phosphate, a controlled substance. Stop using the product and consult your healthcare provider for any health concerns.
What should consumers do?
Stop using the product immediately. Consult your healthcare provider for any health concerns. Contact the recalling firm if you have questions. Report any health product related side effects to Health Canada.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
A potential safety risk has been identified with this product. Stop using it immediately and follow the instructions in the official recall notice.
When was this product recalled?
This product was recalled on June 10, 2024.
Is the Taisho Pharmaceutical brand affected by this recall?
Yes, Taisho Pharmaceutical products are affected by this recall. This recall involves Taisho Pharmaceutical Pabron Gold A (Granules) sold in Canada. It's being recalled because it is an unlicensed product and contains dihydrocodeine phosphate, a controlled substance. Stop using the product and consult your healthcare provider for any health concerns.